Treatment of spasticity rel ated to mul tiple scle rosis with intrathecal baclofen: A long-term folow-up

Journal of Rehabilitation Medicine

Volumn 43, Issue 6, 2011, Pages 511-514

  Rekand, Tiina ^a   Grønning, Marit ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Baclofen; ITB; Multiple sclerosis; Pain; Rehabilitation; Spasticity

Indexed keywords

BACLOFEN; CENTRAL MUSCLE RELAXANT;

ADULT; ARTICLE; CASE REPORT; DISABILITY; DRUG IMPLANT; FEMALE; FOLLOW UP; HUMAN; INTRASPINAL DRUG ADMINISTRATION; MIDDLE AGED; MULTIPLE SCLEROSIS; SPASTICITY; TIME; TREATMENT OUTCOME;

ADULT; BACLOFEN; DISABILITY EVALUATION; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SPINAL; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959511307     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0811     Document Type: Article

References (19)

1. Ward AB. Spasticity treatment with botulinum toxins. J Neural Transm 2008; 115: 607-616.
2. Penn RD. Intrathecal baclofen for severe spasticity. Ann N Y Acad Sci 1988; 531: 157-166.
3. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoes CB, Mclaughlin JF. Long-term baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003; 98: 291-295. (Pubitemid 36151022)
4. Dario A, Tomei G. A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf 2004; 27: 799-818. (Pubitemid 39243562)
5. Sadiq SA, Wang GC. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. J Neurol 2006; 253: 563-569. (Pubitemid 43876984)
6. Dario A, Di Stefano MG, Grossi A, Casagrande F, Bono G. Longterm intrathecal baclofen infusion in supraspinal spasticity of adulthood. Acta Neurol Scand 2002; 105: 83-87. (Pubitemid 34188366)
7. Zahavi A, Geertzen AHB, Middel B, Staal M, Rietman JS. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry 2004; 75: 1553-1557. (Pubitemid 39430606)
8. Rizzo MA, Hadjimichael OC, Preingerova J, Vollmer TC. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004; 10: 589-595. (Pubitemid 39207235)
9. Ridley B. Intrathecal baclofen therapy: challenges in patients with multiple sclerosis. Rehabil Nurs 2006; 31: 158-164.
10. Heetla HW, Staal MJ, Kilphuis C, van Laar T. The incidence of tolerance in intrathecal baclofen therapy. Spinal Cord 2009; 47: 751-756.
11. Azouvi P, Mane M, Thiebaut J-B, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996: 77: 36-39.
12. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (ED SS). Neurology 1983; 33: 1444-1452. (Pubitemid 14237132)
13. Biering-Sørensen F, Nielsen JB, Klinge K. Spasticity assessment: a review. Spinal Cord 2006; 44: 708-722.
14. Saval A, Chiodo AE. Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin. J Spinal Cord Med 2010; 33: 16-21.
15. Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D'Allo G, et al. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 2004; 63: 919-921. (Pubitemid 39297662)
16. Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G. A clinical study of Intrathecal baclofen using a programmable pump for intrathecal spasticity. Arch Phys Med Rehabil 2005; 86: 2165-2171. (Pubitemid 41566214)
17. Pöllmann W, Feneberg W. Current management of pain associated with multiple sclerosis. CNS Drugs 2008; 22: 291-324. (Pubitemid 351367440)
18. Lind G, Schechtmann G, Winter J, Meyerson BA, Linderoth B. Baclofen-enhanced spinal cord stimulation and intrathecal baclofen alone for neuropathic pain: long term outcome of pilot study. Eur J Pain 2008; 12: 132-136. (Pubitemid 350046366)
19. Ørsnes GB, Sørensen PS, Larsen TK, Ravnborg M. Effect of baclofen on gait in spastic MS patients. Acta Neurol Scand 2000; 101: 244-248. (Pubitemid 30155151)